O15553 (MEFV_HUMAN) Homo sapiens (Human)
Pyrin UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
7 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
14-3-3 in complex with PyrinpS208pS242 |
Heteromer P31947; | 1×B3P; | ||||
Assess | ||||||
Crystal structure of 14-3-3 in complex with PyrinpS242 and a protein/peptide interface fragment |
Heteromer P31947; | 2×463; 2×PE5; 2×MG; 2×CA; | ||||
Assess | ||||||
14-3-3 in complex with Pyrinp pS242 |
Heteromer P31947; | |||||
Assess | ||||||
Hydrophobic Interactions Drive the Tetrameric Assembly of the TRIM20 Coiled-Coil Domain | homo-4-mer | |||||
Assess | ||||||
Crystal structure of the CHS-B30.2 domains of TRIM20 | homo-2-mer | 2×SO4; 1×EDO; | ||||
Assess | ||||||
Pyrin PrySpry domain | monomer | 2×SCN; 3×EDO; | ||||
Assess | ||||||
Solution structure of the pyrin domain of human Pyrin | monomer | |||||
Assess |
3 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4cg4.1.A | homo-2-mer | 0.77 | 100.00 | |||
Assess | ||||||
7xt2.1.A | homo-2-mer | 0.62 | 2×ZN; | 20.97 | ||
Assess | ||||||
4tn3.1.A | homo-2-mer | 0.50 | 2×ZN; | 25.76 | ||
Assess |
8 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 1 | 4cg4.1.A | homo-2-mer | 0.81 | 100.00 | ||
Assess | ||||||
Isoform 1 | 7xt2.1.A | homo-2-mer | 0.63 | 2×ZN; | 21.02 | |
Assess | ||||||
Isoform 1 | 6qaj.1.A | homo-2-mer | 0.52 | 14.29 | ||
Assess | ||||||
Isoform 1 | 4tn3.1.A | homo-2-mer | 0.50 | 2×ZN; | 25.76 | |
Assess | ||||||
Isoform 3 | 4cg4.1.A | homo-2-mer | 0.64 | 78.70 | ||
Assess | ||||||
Isoform 3 | 5f7t.2.A | monomer | 0.53 | 30.15 | ||
Assess | ||||||
Isoform 3 | 6qaj.1.A | homo-2-mer | 0.51 | 14.29 | ||
Assess | ||||||
Isoform 3 | 5iea.1.A | homo-3-mer | 0.51 | 35.20 | ||
Assess |